Total Pageviews

Monday, August 22, 2022

Another Step...

 


This piece notes, Gilead's Sunlenca (lenacapavir) has been approved in Europe for a twice yearly injection to treat HIV.  This article has some interesting info on the matter.  The Wiki page has a bit more on technical of the drug.  This med is primarily meant for combating the virus in those with multidrug resistant HIV.  It will also be helpful in places/peoples where regular regimen adherence is difficult.  Give this a read.

Cya..

No comments:

Post a Comment